Dash Bio Featured Articles

1. Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO 9/2/2025

   In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.

2. Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows 9/2/2025

   Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.

3. Why Bioanalysis Needs To Break Free From Manual Bottlenecks 9/2/2025

   Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.